Main content
NICE refuses to approve Lucentis for Diabetic Macular Oedema. 26/07/11
We look at the impact of NICE's decision not to approve a drug used for treating diabetic macular oedema, a condition affecting 50 000 people in the UK. Plus more from Sight Vilage, the exhibition which showcases the latest technology for blind and partially sighted people.
Last on
Tue 26 Jul 201120:40
BBC Radio 4
Broadcast
- Tue 26 Jul 201120:40BBC Radio 4
Download this programme
Podcast
![]()
In Touch
News, views and information for people who are blind or partially sighted


